<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>African Continental Ancestry Group | Drögemöller Lab</title>
    <link>/tag/african-continental-ancestry-group/</link>
      <atom:link href="/tag/african-continental-ancestry-group/index.xml" rel="self" type="application/rss+xml" />
    <description>African Continental Ancestry Group</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Thu, 01 Jan 2015 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_2.png</url>
      <title>African Continental Ancestry Group</title>
      <link>/tag/african-continental-ancestry-group/</link>
    </image>
    
    <item>
      <title>Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohort</title>
      <link>/publication/dodgen-evaluation-2015/</link>
      <pubDate>Thu, 01 Jan 2015 00:00:00 +0000</pubDate>
      <guid>/publication/dodgen-evaluation-2015/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Patterns of variation influencing antipsychotic treatment outcomes in South African first-episode schizophrenia patients</title>
      <link>/publication/drogemoller-patterns-2014/</link>
      <pubDate>Sat, 01 Feb 2014 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-patterns-2014/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study</title>
      <link>/publication/dodgen-introduction-2013/</link>
      <pubDate>Tue, 01 Jan 2013 00:00:00 +0000</pubDate>
      <guid>/publication/dodgen-introduction-2013/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort</title>
      <link>/publication/wright-association-2012/</link>
      <pubDate>Mon, 01 Oct 2012 00:00:00 +0000</pubDate>
      <guid>/publication/wright-association-2012/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications</title>
      <link>/publication/drogemoller-whole-genome-2011/</link>
      <pubDate>Thu, 01 Dec 2011 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-whole-genome-2011/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Characterization of the genetic profile of CYP2C19 in two South African populations</title>
      <link>/publication/drogemoller-characterization-2010/</link>
      <pubDate>Sun, 01 Aug 2010 00:00:00 +0000</pubDate>
      <guid>/publication/drogemoller-characterization-2010/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population</title>
      <link>/publication/wright-elucidation-2010/</link>
      <pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate>
      <guid>/publication/wright-elucidation-2010/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
